Adenosine kinase inhibitors augment release of adenosine from spinal cord slices

European Journal of Pharmacology

Volumn 307, Issue 2, 1996, Pages 157-162

  Golembiowska, Krystyna ^a,b   White, Thomas D ^a   Sawynok, Jana ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Adenosine; Adenosine deaminase; Adenosine kinase; Spinal cord

Indexed keywords

5 IODOTUBERCIDIN; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; PENTOSTATIN;

ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SPINAL CORD;

EID: 0030603728     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00248-8     Document Type: Article

References (35)

1. Cahill, C.M., T.D. White and J. Sawynok, 1995, Spinal opioid receptors and adenosine release: neurochemical and behavioural characterization of opioid subtypes, J. Pharmacol. Exp. Ther. 275, 84.
2. 2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiographic study, J. Pharmacol. Exp. Ther. 247, 757.
3. Craig, C.G. and T.D. White, 1993, N-Methyl-D-aspartate-and non-N-methyl-D-aspartate-evoked adenosine release from rat conical slices: distinct purinergic sources and mechanisms of release, J. Neurochem. 60, 1073.
4. Davies, L.P., J. Baird-Lambert and J.F. Marwood, 1986, Studies on several pyrrolo[2,3-d]pyrimidme analogues of adenosine which lack significant agonist activity at A1 and A2 receptors but have potent pharmacological activity in vivo, Biochem. Pharmacol. 35, 3021.
5. Davies, L.P., D.D. Jamieson, J.A. Baird-Lambert and R. Kazlauskas, 1984. Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: pharmacological activities and potent inhibition of adenosine kinase, Biochem. Pharmacol. 33, 347.
6. 2 adenosine receptors in spinal mechanisms of antinociception, Eur. J. Pharmacol. 139, 215.
7. DeLander, G.E., H.I. Mosberg and F. Porreca, 1992, Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice, J. Pharmacol. Exp. Ther. 263, 1097.
8. Fyffe, R.E.W. and E.R. Perl, 1984, Is ATP a central synaptic mediator for certain primary afferent fibres from mammalian skin?, Proc. Natl. Acad. Sci. USA 81, 6890.
9. Geiger, J.D. and J.I. Nagy, 1986, Distribution of adenosine deaminase activity in rat brain and spinal cord, J. Neurosci. 6, 2707.
10. Geiger, J.D., F.S. LaBella and J.I. Nagy, 1984, Characterization and localization of adenosine receptors in rat spinal cord, J. Neurosci. 4, 2303.
11. Golembiowska, K., T.D. White and J. Sawynok, 1995, Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors, Brain Res. 699, 315.
12. Karlsten, R., T. Gordh, P. Hartvig and C. Post, 1990, Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarboxamide-adenosine on nociception and motor function in the rat, Anesth. Analg. 71, 60.
13. Keil, G.J. and G.E. DeLander, 1992, Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor, Life Sci. 51, 171.
14. Keil, G.L. and G.E. DeLander, 1994, Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine-and opioid agonist-induced antinociception in mice, Eur. J. Pharmacol. 271, 37.
15. Malmberg, A.B. and T.L. Yaksh, 1993, Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction, Anesthesiology 79, 270.
16. Massillon, D., W. Stalmans, G. Van de Werve and M. Bollen, 1994, Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor, Biochem. J. 299, 123.
17. Meghji, P., 1991, Adenosine production and metabolism, in: Adenosine in the Nervous System, ed. T. Stone (Academic Press, London) p. 25.
18. Miller, R.L., D.L. Adamczyk, W.H. Miller, G.W. Koszalka, J.L. Rideout, L.M. Beacham, E.Y. Chao, J.J. Haggerty, T.A. Krenitsky and G.B. Elion, 1979, Adenosine kinase from rabbit liver, II. Substrate and inhibitor specificity, J. Biol. Chem. 254, 2346.
19. 2α to conscious mice, Pain 50, 223.
20. Murray, T.F., G. Zhang and P.H. Franklin, 1993, Manipulation of endogenous adenosine affects seizure susceptibility, Drug Dev. Res. 28. 410.
21. Nagy, J.I. and P.E. Dadonna, 1985, Anatomical and cytochemical relationships of adenosine deaminase-containing primary afferent neurons in the rat, Neuroscience 15, 799.
22. Newby, A.C., 1981, The interaction of inhibitors with adenosine metabolizing enzymes in intact isolated cells, Biochem. Pharmacol. 30, 2611.
23. Padua, R., J.D. Geiger, S. Dambock and J.I. Nagy, 1990, 2′-Deoxycoformycin inhibition of adenosine deaminase in rat brain: in vivo and in vitro analysis of specificity, potency, and enzyme recovery, J. Neurochem. 54, 1169.
24. Pak, M.A., H.L. Haas, U.K.M. Decking and J. Schrader, 1994, Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices, Neuropharmacology 33, 1049.
25. Poon, A. and J. Sawynok, 1995, Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration, Eur. J. Pharmacol. 286, 177.
26. Salter, M.W., Y. De Koninck and J.L. Henry, 1993, Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn, Prog. Neurobiol. 41, 125.
27. Sawynok, J., 1991, Adenosine and pain, in: Adenosine and Adenine Nucleotides as Regulators of Cellular Function, ed. J.W. Phillis (CRC, Boca Raton) p. 391.
28. Sawynok, J., 1996, Purines and nociception, in: Purinergic Approaches in Experimental Therapeutics, ed. K. Jacobson and M.F. Jarvis (Wiley and Sons).
29. Sawynok, J., J.W. Downie, A.R. Reid, C.M. Cahill and T.D. White, 1993, ATP release from dorsal spinal cord synaptosomes: characterization and neuronal origin, Brain Res. 610, 32.
30. Sciotti, V.M. and D.G.L. Van Wylen, 1993, Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase, J. Cereb. Blood Flow Metab. 13, 201.
31. Sosnowski, M. and T.L. Yaksh, 1989, Role of spinal adenosine receptors in modulating the hyperesthesia produced by spinal glycine receptor antagonism, Anesth. Analg. 69, 587.
32. + release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord, J. Pharmacol. Exp. Ther. 248, 447.
33. White, T.D., 1996, Potentiation of excitatory amino acid-evoked adenosine release from rat cortical slices by inhibitors of adenosine kinase and adenosine deaminase and by AICAR (acadesine), Eur. J. Pharmacol.
34. Wu, P.H., R.A. Barraco and J.W. Phillis, 1984, Further studies on the inhibition of adenosine uptake into rat brain synaptosomes by adenosine derivatives and methylxanthines, Gen. Pharmacol. 15, 251.
35. Zhang, G., P.H. Franklin and T.F. Murray, 1993, Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility, J. Pharmacol. Exp. Ther. 264, 1415.